Notably, the clone formation and EdU assays showed that EFTUD2 overexpression significantly enhanced cell survival and proliferation under 5-FU treatment; however, such effects on impairing the chemotherapy sensitivity of CRC cell to 5-FU was abolished upon down-regulation of c-MYC (Fig. 8C and D). Here, EFTUD2 is linked to colorectal carcinoma.